The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: Frequency, specificity, and T-cell receptor usage of pp65-specific CTL

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 7569-7579

  Wills, Mark R ^a   Carmichael, Andrew J ^a   Mynard, Kim ^a   Jin, Xia ^a   Weekes, Michael P ^a   Plachter, Bodo ^b   Sissons, J G Patrick ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; STRUCTURAL PROTEIN; T LYMPHOCYTE RECEPTOR;

ALLELE; ANTIGEN PRESENTATION; ARTICLE; CHROMOSOME REARRANGEMENT; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GENE FREQUENCY; HAPLOTYPE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; VIRUS CARRIER; VIRUS INFECTION;

EID: 0029847916     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.7569-7579.1996     Document Type: Article

References (34)

1. Aebischer, T., S. Oehen, and H. Hengartner. 1990. Preferential usage of V alpha 4 and V beta 10 T cell receptor genes by lymphocytic choriomeningitis virus glycoprotein-specific H-2Db-restricted cytotoxic T cells. Eur. J. Immunol. 20:523-531.
2. Alp, N. J., T. D. Allport, J. Van-Zanten, B. Rodgers, J. G. P. Sissons, and L. K. Borysiewicz. 1991. Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein. J. Virol. 65: 4812-4820.
3. Barnes, P. D., and J. E. Grundy. 1992. Down regulation of the class I HLA heterodimer and β2 microglobulin on the surface of cells infected with cytomegalovirus. J. Gen. Virol. 73:2395-2403.
4. Beersma, M. F. C., M. J. E. Bijlmakers, and H. L. Ploegh. 1993. Human cytomegalovirus down regulates HLA class I expression by reducing the stability of class I H chains. J. Immunol. 151:4455-4464.
5. Borysiewicz, L. K., J. Hickling, S. Graham, J. Sinclair, M. Cranage, G. Smith, and J. G. P. Sissons. 1988. Human cytomegalovirus specific cytoloxic T cells - relative frequency of stage specific CTL recognising the 72KDa immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J. Exp. Med. 168:919-931.
6. Bowness, P., P. A. Moss, S. Rowland-Jones, J. I. Bell, and A. J. McMichael. 1993. Conservation of T cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigenspecific major histocompatibility complex class I-restricted responses. Eur. J. Immunol. 23:1417-1421.
7. Browne, H., G. Smith, S. Beck, and T. Minson. 1990. A complex between the class I MHC homologue encoded by human cytomegalovirus and beta2 microglobulin. Nature (London) 347:770-772.
8. Carmichael, A., X. Jin, J. G. P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1) specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249-256.
9. Cha, T. A., E. Tom, G. W. Kemble, G. M. Duke, E. S. Mocarski, and R. R. Spaete. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70:78-83.
10. Cranage, M. P., T. Kouzarides, A. T. Bankier, S. Satchwell, K. Weston, P. Tomlinson, B. Barrell, H. Hart, S. E. Bell, A. C. Minson, and G. L. Smith. 1986. Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. J. EMBO 5:3057-3063.
11. Dhib-Jalbut, S., D. E. McFarlin, and H. F. McFarland. 1989. Measles virus polypeptide specificity of the cytotoxic T lymphocyte response in multiple sclerosis. J. Neuroimmunol. 21:205-212.
12. Gavin, M. A., M. J. Gilbert, S. R. Riddell, P. D. Greenberg, and M. J. Bevan. 1993. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J. Immunol. 151:3971-3980.
13. Gilbert, M. J., S. R. Riddell, C. R. Li, and P. D. Greenberg. 1993. Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus. J. Virol. 67:3461-3469.
14. Gotch, F. M., A. J. McMichael, G. L. Smith, and B. Moss. 1987. Identification of the virus molecules recognised by influenza specific cytotoxic T lymphocytes. J. Exp. Med. 165:408-416.
15. Kalams, S. A., R. P. Johnson, A. K. Trocha, M. J. Dynan, H. S. Ngo, R. T. D'quila, J. T. Kurnick, and B. D. Walker. 1994. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1261-1271.
16. Koszinowski, U. H., M. Del Val, and M. Reddehase. 1990. Cellular and molecular basis of the protective immune response to cytomegalovirus infection. Curr. Top. Microbiol. Immunol. 154:189-220.
17. Lehner, P. J., E. C. Wang, P. A. Moss, S. Williams, K. Platt, S. M. Friedman, J. I. Bell, and L. K. Borysiewicz. 1995. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J. Exp. Med. 181:79-91.
18. McLaughlin-Taylor, E., H. Pande, S. Forman, B. Tanamachi, C. Li, J. Zaia, P. Greenberg, and S. Riddell. 1994. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J. Med. Virol. 43:103-110.
19. McMichael, A. J., M. F. Gotch, D. W. Dongworth, A. Clark, and C. W. Potter. 1983. Declining T-cell immunity to influenza, 1977-82. Lancet ii:762-764.
20. Moss, P. A., R. J. Moots, W. M. Rosenberg, S. J. Rowland-Jones, H. C. Bodmer, A. J. McMichael, and J. I. Bell. 1991. Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc. Natl. Acad. Sci. USA 88: 8987-8990.
21. Quinnam, G. V., W. H. Burns, N. Kirmani, A. H. Rook, J. F. Manischewitz, L. Jackson, G. W. Santos, and R. Saral. 1984. HLA restricted cytotoxic T lymphocytes arc an early immune response and important defense mechanism in cytomegalovirus infections. Rev. Infect. Dis. 6:156-163.
22. Quinnam, G. V., N. Kirmani, A. H. Rook, J. F. Manischewitz, L. Jackson, G. Moreschi, G. W. Santos, R. Saral, and W. H. Burns. 1982. Cytotoxic T cells in cytomegalovirus infection: HLA restricted T lymphocyte and non T lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus in bone marrow transplant recipients. N. Engl. J. Med. 307:7-13.
23. Rammensee, H. G., T. Friede, and S. Stevanoviic. 1995. MHC ligands and peptide motifs: first listing. Immunogenctics 41:178-228.
24. Reusser, P., S. R. Riddell, J. D. Meyers, and P. D. Greenberg. 1991. Cytotoxic T lymphocyte response to cytomegalovirus following allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus and disease. Blood 78:1373-1380.
25. Riddell, S. R., M. Rabin, A. P. Gaballe, W. J. Britt, and P. D. Greenberg. 1991. Class I MHC restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. J. Immunol. 146:2795-2804.
26. Schmolke, S., H. F. Kern, P. Drescher, G. Jahn, and B. Plachter. 1995. The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture. J. Virol. 69:5959-5969.
27. Spaete, R. R., R. C. Gehrz, and M. P. Landini. 1994. Human cytomegalovirus structural proteins. J. Gen. Virol. 75:3287-3308.
28. Venet, A., and B. D. Walker. Cytotoxic Tcell epitopes in HIV/SIV infection. 1993. AIDS 7(Suppl 1):117-126.
29. Wallace, L. E., R. J. Murray, S. P. Lee, and A. B. Rickinson. 1993. Cell mediated immunity to Epstein-Barr virus, p. 447-472. In D. B. Thomas (ed.), Viruses and cellular immune responses. Marcel Dekker Inc., New York.
30. Walter, E. A., P. D. Greenberg, M. J. Gilbert, R. J. Finch, K. S. Watanabe, E. D. Thomas, and S. R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1038-1044.
31. Warren, A. P., D. H. Ducroq, P. J. Lehner, and L. K. Borysiewicz. 1994. Human cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and arc resistant to lysis by cytotoxic T lymphocytes. J. Virol. 68:2822-2829.
32. Yamashita, Y., K. Shimokata, S. Mizuno, and Y. Nishiyami. 1993. Down regulation of the surface expression of class I MHC antigens by human cytomegalovirus. Virology 193:727-736.
33. Yanagi, Y., R. Maekawa, T. Cook, O. Kanagawa, and M. B. Oldstone. 1990. Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus. J. Virol. 64:5919-5926.
34. Yanagi, Y., A. Tishon, H. Lewicki, B. A. Cubitt, and M. B. Oldstone. 1992. Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule. J. Virol. 66:2527-2531.